Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Irinotecan 300mg/15ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) |
| BNF code | 0801050Q0AAACAC |
| Virtual Medicinal Product | Irinotecan 300mg/15ml solution for infusion vials |
| Name | Irinotecan 300mg/15ml concentrate for solution for infusion vials |
| Abbreviated name | Irinotecan 300mg/15ml concentrate for inf vials |
| Supplier | Seacross Pharmaceuticals Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intravenous |
| Actual Medicinal Product Packs | |
| Irinotecan 300mg/15ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_8.0.0_20250804000001, imported on 4th August 2025 at 05:02:57.